<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: channels</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'channels'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22channels%22&t=%22channels%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:14:24 +0100</lastBuildDate>
        <item>
            <title>Radiographic Diagnosis of Liver Hemangioma</title>
            <link>http://www.medworm.com/index.php?rid=4309543&amp;cid=t_196773_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2011%2F01%2Fradiographic-diagnosis-liver-hemangioma%2F</link>
            <description>Hemangiomas are the most common liver tumor and are often found incidentally during radiographic screening for other conditions.
Hemangiomas are benign collections of disorganized vascular channels and if asymptomatic do not require follow-up. Characteristic radiographic computed tomography findings are peripheral nodular enhancement with delayed centripetal enhancement.
Hemangiomas with atypical features or that are symptomatic require further work-up and consideration for treatment. The bleeding risk of large hemangioms is unknown. However, some experienced liver surgeons may elect to treat large lesions secondary to size and position in the liver parenchyma.

Hemangiomas are the most common liver tumor and are often found incidentally during radiographic screening for other conditions.
...</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4309543</comments>
            <pubDate>Tue, 04 Jan 2011 06:04:01 +0100</pubDate>
            <guid isPermaLink="false">4309543</guid>        </item>
        <item>
            <title>Medicine And The Internet: 2000 Vs. 2010</title>
            <link>http://www.medworm.com/index.php?rid=4133709&amp;cid=t_196773_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fscienceroll.files.wordpress.com%2F2010%2F10%2Fmayo-today.jpg</link>
            <description>Whenever I talk to doctors about using social media in medicine, they seem to think there are more cons than pros regarding this issue. I like reminding them about some major differences between 2000 and today:



What would I do if&amp;#8230;
In 2000
Today


I need clinical answer
Try to find a collegue who knows it
Post a question on Twitter


I want to hear patient story about a specific condition
Try to find a patient in my town
Read blogs, watch YouTube


I want to be up-to-date
Go to the library once a week
Use RSS and follow hundreds of journals


I want to work on a manuscript with my team
We gather around the table
Use Google Docs without geographical limits



 (more&amp;#8230;)

			
			*This blog post was originally published at ScienceRoll* (Source: Better Health)</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4133709</comments>
            <pubDate>Thu, 04 Nov 2010 16:00:33 +0100</pubDate>
            <guid isPermaLink="false">4133709</guid>        </item>
        <item>
            <title>The Future of Pharma Marketing</title>
            <link>http://www.medworm.com/index.php?rid=3672040&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2Fpiq0EYh4WEo%2Ffuture-of-pharma-marketing.html</link>
            <description>According to Manhattan research, the future of Pharma Marketing is digital. This is moving away from marketing to the doctors who were the gate keepers of all information. Now with the digital shift moving to consumers having more information and coming to doctors more informed, marketing of the Pharma companies is having to shift to adopt to this. Read the full Manhattan Research Report here. (Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3672040</comments>
            <pubDate>Thu, 17 Jun 2010 15:31:00 +0100</pubDate>
            <guid isPermaLink="false">3672040</guid>        </item>
        <item>
            <title>Why should you attend the Multi Channel Pharma Marketing Event?</title>
            <link>http://www.medworm.com/index.php?rid=3618093&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FW67mC4E4R7U%2Fwhy-should-you-attend-multi-channel.html</link>
            <description>What are the top 10 reasons you should attend?● Break Down Silos to Identify New Marketing Insights and Opportunities● Get the Most Out of Your Agency Partnerships From Contract to Execution● Prepare for the Paradigm Marketing Shift Created by the New Economic and Regulatory Environment● Enhance Patient-Provider Relationships to Achieve True Return on Engagement● Adopt Actionable Segmentation Techniques to Drive Market Growth● Improve Mission Critical Managed Care Partnerships to Secure Market Access● Take Value Add to the Next Level to Differentiate Your Brand and Build Sustainable Relationships● Evaluate the ROI of Your Media Plan Without Getting Bogged Down in the Data● Bring the Customer to You With Live Physician, Patient, and Payer Focused Break Groups● Debate the...</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3618093</comments>
            <pubDate>Tue, 01 Jun 2010 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">3618093</guid>        </item>
        <item>
            <title>Ending the Black Market in Low-skilled Labor</title>
            <link>http://www.medworm.com/index.php?rid=3429160&amp;cid=t_196773_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FNAy9l6EF2gI%2F</link>
            <description>By Daniel GriswoldAlex Nowrasteh and Ryan Young of the Competitive Enterprise Institute make the case for immigration reform in an especially appealing way in a fresh op-ed this week in the Detroit News.
In a commentary article titled, “Fix immigration rules to crush black market,” they dissect a well-meaning but flawed Obama administration effort to fix the dysfunctional H-2A visa program for temporary farm workers. Instead of fine tuning an unworkable law, Nowrasteh and Young advocate liberalization:
That means making H-2A visas inexpensive, easy to obtain, and keeping the related paperwork and regulations to a minimum. That means no minimum wage hike. No costly background check requirements. People rarely break laws that are reasonable and easy to obey.
When legal channels cost too ...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3429160</comments>
            <pubDate>Thu, 01 Apr 2010 15:42:49 +0100</pubDate>
            <guid isPermaLink="false">3429160</guid>        </item>
        <item>
            <title>Pharma's New Home Lies at the Corner of Facebook and Twitter</title>
            <link>http://www.medworm.com/index.php?rid=3251398&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FnfW_qVVBygs%2Fpharmas-new-home-lies-at-corner-of.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3251398</comments>
            <pubDate>Mon, 08 Feb 2010 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">3251398</guid>        </item>
        <item>
            <title>Lights, Camera, Health! New Study Shows Online Health Videos Drive Consumers to Take Action</title>
            <link>http://www.medworm.com/index.php?rid=3244052&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2F92zihr3_OQ4%2Flights-camera-health-new-study-shows.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3244052</comments>
            <pubDate>Fri, 05 Feb 2010 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">3244052</guid>        </item>
        <item>
            <title>Henry Markram on TED – video online</title>
            <link>http://www.medworm.com/index.php?rid=2920353&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fwww.almaden.ibm.com%2Finstitute%2Fresources%2F2006%2FDisk2.avi</link>
            <description>We had read that Dr. Henry Markram of the Blue Brain project had given a talk at TED (technology, entertainment, design), but the video wasn&amp;#8217;t released until this month.  This talk is geared towards a general audience, rather than getting into the specific details of the Blue Brain project, as he has before.  It is engaging and includes many suggestions towards the future of neuroscience and AI.
Watch it online at the TED website. (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2920353</comments>
            <pubDate>Thu, 22 Oct 2009 17:20:25 +0100</pubDate>
            <guid isPermaLink="false">2920353</guid>        </item>
        <item>
            <title>Influenza M2 Channel</title>
            <link>http://www.medworm.com/index.php?rid=2886207&amp;cid=t_196773_77_f&amp;fid=37259&amp;url=http%3A%2F%2Fwww.horizonpress.com%2Fblogger%2F2009%2F10%2Finfluenza-m2-channel.html</link>
            <description>Viral ion channels have minimalist architecture. Despite their relatively simple structure, viral channels can achieve highly specific gating and selection of ions, and the particular mechanisms appear to be different from those of prokaryotes and eukaryotes. The unique structural and functional properties of viral channels make them ideal targets for antiviral therapy because the molecules that inhibit viral ion channels may not interact with human ion channels. The M2 proton channel of influenza A virus is a model viral ion channel. This small channel, whose pore is formed by four equivalent transmembrane helices, is the target of two widely used anti-influenza A drugs, amantadine and rimantadine, both belonging to the adamantane class of compounds. However, resistance of influenza A to ...</description>
            <author>Microbiology Blog: The weblog for microbiologists.</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2886207</comments>
            <pubDate>Mon, 12 Oct 2009 15:42:00 +0100</pubDate>
            <guid isPermaLink="false">2886207</guid>        </item>
        <item>
            <title>New Multi-Marketing Channel Strategies for Pharma</title>
            <link>http://www.medworm.com/index.php?rid=2865916&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FTPExYF5sNhs%2Fnew-multi-marketing-channel-strategies.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2865916</comments>
            <pubDate>Tue, 06 Oct 2009 14:07:00 +0100</pubDate>
            <guid isPermaLink="false">2865916</guid>        </item>
        <item>
            <title>Inert designer ligand-receptor for genetically targeted activation</title>
            <link>http://www.medworm.com/index.php?rid=2667549&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F08%2F03%2Finert-designer-ligand-receptor-for-genetically-targeted-activation%2F</link>
            <description>Recently, Alexander et al. published Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors [Neuron Neurotechniques], in which they use directed evolution techniques to modify a muscarinic GPCR to selectively bind an orally-deliverable small molecule that is otherwise inert. Apparently, this is the first time a channel has been engineered such that is selective for a biologically inert molecule, providing specificity of action. (They compare their technology with the hyperpolarizing allatostatin receptor which can have off-target effects.) Because the channel is specified genetically and the drug circulates systemically, it is easier to activate large populations of neurons (viz. optogenetic methods which are constrained to neurons in the ligh...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2667549</comments>
            <pubDate>Tue, 04 Aug 2009 01:44:51 +0100</pubDate>
            <guid isPermaLink="false">2667549</guid>        </item>
        <item>
            <title>How to Network With Busy People – Part 3</title>
            <link>http://www.medworm.com/index.php?rid=2657949&amp;cid=t_196773_180_f&amp;fid=38613&amp;url=http%3A%2F%2Fwww.stevepavlina.com%2Fblog%2F2009%2F07%2Fhow-to-network-with-busy-people-part-3%2F</link>
            <description>This is a continuation of the “How to Network With Busy People” series. The first post in the series can be found here.
Continuing on with our tips…
Avoid making threats.
An example of a threat is, &amp;quot;I really need a response from you, so I&amp;#8217;m going to keep calling/emailing you every day until you respond.&amp;quot;
In my experience most people have the good sense not to use threats, but it does happen now and then – enough that I can call it out as a pattern.
Threats are almost always counter-productive. If you behave with such gross immaturity, you’ll simply paint yourself as a psycho, and the busy person will want nothing to do with you.
I know it can be frustrating when you don&amp;#8217;t get the reply you&amp;#8217;re hoping for, but don&amp;#8217;t make matters worse by threatenin...</description>
            <author>Steve Pavlina's Personal Development Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2657949</comments>
            <pubDate>Fri, 31 Jul 2009 10:15:00 +0100</pubDate>
            <guid isPermaLink="false">2657949</guid>        </item>
        <item>
            <title>Gastric-Band Maker Reaches Out With YouTube Channel</title>
            <link>http://www.medworm.com/index.php?rid=2580468&amp;cid=t_196773_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FIKOVlmQSiVw%2Fgastric-band-maker-reaches-out-with.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2580468</comments>
            <pubDate>Tue, 07 Jul 2009 15:56:00 +0100</pubDate>
            <guid isPermaLink="false">2580468</guid>        </item>
        <item>
            <title>Sunday afternoon reading: Genetic tools “primer”</title>
            <link>http://www.medworm.com/index.php?rid=2405720&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F05%2F10%2Fsunday-afternoon-reading-genetic-tools-primer%2F</link>
            <description>I came across this fantastic review of tools for the Genetic Dissection of Neural Circuits in Neuron a few days ago. It&amp;#8217;s by Liqun Luo, Ed Callaway, and Karel Svoboda. I highly recommend it, as it spans the gamut from genetic targeting (recombination, binary logic, viral delivery) to circuit reconstruction (super resolution LM, EM, brainbow) to activity modulation and functional mapping (uncaging, artificial GPCRs, light-gated channels, MIST). I don&amp;#8217;t think I&amp;#8217;ve ever seen quite a review of so many cutting edge neurotechnologies in one place. I can&amp;#8217;t recommend this piece enough really. For me, with my lack of molecular expertise, the first sections on combinatorial gene targeting/expression techniques were great, pulling together Gal4, Cre/Flp, and Tet systems into a...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2405720</comments>
            <pubDate>Sun, 10 May 2009 22:04:56 +0100</pubDate>
            <guid isPermaLink="false">2405720</guid>        </item>
        <item>
            <title>Neuroengineering in Wired</title>
            <link>http://www.medworm.com/index.php?rid=2232622&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F03%2F03%2Fneuroengineering-in-wired%2F</link>
            <description>Rewiring the Brain: Inside the New Science of Neuroengineering.
Interviews Boyden and Deisseroth. Follow the link a video of an optogenetically controlled mouse. (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2232622</comments>
            <pubDate>Tue, 03 Mar 2009 04:27:15 +0100</pubDate>
            <guid isPermaLink="false">2232622</guid>        </item>
        <item>
            <title>Deisseroth on new step ChR2</title>
            <link>http://www.medworm.com/index.php?rid=2210494&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F02%2F24%2Fdeisseroth-on-new-step-chr2%2F</link>
            <description>Nature methods has a small piece interviewing Karl Deisseroth on properties of the new step ChR2.
Some shortcomings of step ChR2 and future research directions:
Deisseroth expects ongoing efforts to improve key features of these channels. &amp;#8220;One disadvantage is that some of the mutants have reduced current compared to wild type, so multiple mutations may help to bring those current levels back up to wild-type levels,&amp;#8221; he says. Projects designed to improve membrane targeting and to apply a composite of opsins, including the red light–responsive channelrhodopsin from Volvox carteri, are also in the works in his laboratory. (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2210494</comments>
            <pubDate>Tue, 24 Feb 2009 17:01:18 +0100</pubDate>
            <guid isPermaLink="false">2210494</guid>        </item>
        <item>
            <title>sCRACM: ChR2 circuit mapping</title>
            <link>http://www.medworm.com/index.php?rid=2149626&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F01%2F31%2Fscracm-chr2-circuit-mapping%2F</link>
            <description>As has become a hallmark of the Svoboda lab, this new paper in Nature (advance online publication) combines several cutting edge technologies (rAAV-delivered ChR2, most prominently, and 2-photon stimulation) to do some interesting synaptic physiology.
The subcellular organization of neocortical excitatory connections : Article : Nature.
They used ChR2 (with TTX and 4-AP to block action potentials) to find where on the dendritic tree particular inputs synapsed onto L3 and L5 cells and to measure the strength of those inputs. ChR2 depolarizes the input axon locally (60um spot diameter) at points of (potential) axodendritic contact. If you&amp;#8217;ve heard the term &amp;#8220;potential synapse&amp;#8221; before, then think of this technique as a way of checking potential synapses and seeing if there re...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2149626</comments>
            <pubDate>Sun, 01 Feb 2009 02:40:17 +0100</pubDate>
            <guid isPermaLink="false">2149626</guid>        </item>
        <item>
            <title>Bistable current photoswitches in neurons</title>
            <link>http://www.medworm.com/index.php?rid=2095863&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2009%2F01%2F12%2Fbistable-current-photoswitches-in-neurons%2F</link>
            <description>Bi-stable neural state switches : Article : Nature Neuroscience
Another channelrhodopsin breakthrough from Deisseroth&amp;#8217;s lab. This time light is not required to keep the channel open. Light merely triggers opening and closing behavior. Blue-shifted light opens channels and red-shifted light closes them. This looks like another potentially powerful neurotechnology for interrogating circuits and systems.
Relevant fig: (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2095863</comments>
            <pubDate>Mon, 12 Jan 2009 05:01:13 +0100</pubDate>
            <guid isPermaLink="false">2095863</guid>        </item>
        <item>
            <title>Adaptive binning in the retina</title>
            <link>http://www.medworm.com/index.php?rid=1856044&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2008%2F10%2F06%2Fadaptive-binning-in-the-retina%2F</link>
            <description>The Circadian Clock in the Retina Controls Rod-Cone Coupling (Christophe Ribelayga, Yu Cao, and Stuart C. Mangel)
An amazing paper from Neuron demonstrating adaptive (circadian clock-governed) binning in the retina, based on dopamine modulation of gap junction (electrical) synapses between retinal photodetectors. During the day, abundant dopamine release weakens gap junctions coupling rods and cones together so that visual acuity is high. When light is scarce (at night), there is less dopamine and the electrical coupling between rods and cones is increased. This is analogous to on-chip binning in CCD (digital) cameras. Binning increases signal (in light-limited systems, eg. seeing at night) by increasing optical input area and by reducing single element noise (ie. noise at different pho...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1856044</comments>
            <pubDate>Mon, 06 Oct 2008 21:00:15 +0100</pubDate>
            <guid isPermaLink="false">1856044</guid>        </item>
        <item>
            <title>Neuroengineering mosquito repellents</title>
            <link>http://www.medworm.com/index.php?rid=1713933&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2008%2F08%2F18%2Fneuroengineering-mosquito-repellents%2F</link>
            <description>There has been a few articles recently in the NYT about the neural mechanisms used by mosquito repellents. What a wonderful idea: Do some ephys recordings to find which neurons are sensitive to DEET (the current standard for mosquito repellents, which I can attest both doesn&amp;#8217;t work very well and eats holes in synthetic clothing) and then build targeted compounds for those receptors/neurons/pathways. I always like this type of simple and practical neuroengineering.
Right now, it appears that there&amp;#8217;s a bit of controversy in the field. Earlier this year, in Science, a group from Rockefeller found that DEET masked sensitivity to human odors by interfering with a particular odorant receptor. This impressive result was recently question by entomologists from UC-Davis in a PNAS paper ...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1713933</comments>
            <pubDate>Tue, 19 Aug 2008 03:05:07 +0100</pubDate>
            <guid isPermaLink="false">1713933</guid>        </item>
        <item>
            <title>Angina drug proves to treat long QT syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1340808&amp;cid=t_196773_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F261962624%2F</link>
            <description>As many as 1000 deaths each year are associated with long QT syndrome. This very scary cardiac arrhythmia puts teen and young persons at risk for sudden cardiac arrest, usually ending in death. These same young ladies and gents have healthy hearts otherwise.
Researchers have found that a drug that is used in cases of angina can safely help to treat QT syndrome&amp;#8230;
In the current, pilot study, researchers found that a drug, ranolazine (brand name Ranexa, CV Therapeutics) shortens the QT interval by about 5 percent; just enough to reduce symptoms and risks associated with one form of LQTS (LQT3-deltaKPQ) 
What happens in long QT syndrome? Changes to ion channels cause channel proteins to leak charged particles which alters the timing of the heartbeat. Isn&amp;#8217;t it really crazy how our b...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1340808</comments>
            <pubDate>Tue, 01 Apr 2008 13:36:17 +0100</pubDate>
            <guid isPermaLink="false">1340808</guid>        </item>
        <item>
            <title>Where are we with this whole free will thing?</title>
            <link>http://www.medworm.com/index.php?rid=1090451&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2007%2F12%2F12%2Fwhere-are-we-with-this-whole-free-will-thing%2F</link>
            <description>Haim Sompolinsky has written an excellent book chapter on the scientific view of free will and choice, pulling in good ideas from physics and neuroscience along with contemporary philosophical commentary.
	I think this chapter might be helpful for neuroscientists outside of the lab. Often a dinner table discussion has moved to the idea of &amp;#8220;quantum consciousness&amp;#8221; or &amp;#8220;quantum free will&amp;#8221;. Often, someone will mention Roger Penrose, who has become something of a poster boy for this idea that quantum indeterminacy (eg. Heisenberg&amp;#8217;s uncertainty principle) is one possible way that free will is really free. And then, people look around and say, &amp;#8220;Well, you&amp;#8217;re a neuroscientist. Do we have free will?&amp;#8221; (And that&amp;#8217;s when I take another big drink or bi...</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1090451</comments>
            <pubDate>Wed, 12 Dec 2007 14:31:43 +0100</pubDate>
            <guid isPermaLink="false">1090451</guid>        </item>
        <item>
            <title>News About Ion Channels</title>
            <link>http://www.medworm.com/index.php?rid=1027083&amp;cid=t_196773_122_f&amp;fid=34755&amp;url=http%3A%2F%2Fneuropsychological.blogspot.com%2F2007%2F11%2Fnews-about-ion-channels.html</link>
            <description>A press release from the NIH:Scientists Zero in on the Cellular Machinery that Enables Neurons to FireIf you ever had a set of Micronauts — toy robots with removable body parts — you probably had fun swapping their heads, imagining how it would affect their behavior. Scientists supported by the National Institutes of Health have been performing similar experiments on ion channels — pores in our nerve cells — to sort out the channels' key functional parts.In the November 15 issue of Nature, one group of researchers shows that a part of ion channels called the paddle is uniquely transplantable between different channels. Writing in the same issue, another group exploited this property to probe the three-dimensional structure of ion channels on an atomic scale.&quot;The effects of many tox...</description>
            <author>BrainBlog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1027083</comments>
            <pubDate>Wed, 14 Nov 2007 20:18:00 +0100</pubDate>
            <guid isPermaLink="false">1027083</guid>        </item>
        <item>
            <title>Are Glucose-Sensing Neurons A Key Aspect In The Development Of Type 2 Diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=832653&amp;cid=t_196773_134_f&amp;fid=36049&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FDiabetesNotes%2F%7E3%2F150317128%2F</link>
            <description>Scientists have revisited the fact that certain neurons in the brain are activated by glucose. And this time they have identified that defects in the brain&amp;#8217;s ability to respond to glucose can play a role in the development of type 2 diabetes. How is this research of clinical use you ask&amp;#8230;
&amp;#8220;By identifying glucose-sensing neurons in the brain as important players in regulating glucose, our findings may open a new avenue of research,&amp;#8221; Dr. Coppari said. &amp;#8220;Because these neurons play a role in maintaining glucose homeostasis throughout the body, an impairment in their glucose-sensing ability could play a pathogenic role in type 2 diabetes, where homeostasis is altered.&amp;#8221;
In a nut shell, curb the glucose-sensing neurons into reacting appropriately and there is a d...</description>
            <author>Diabetes Notes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=832653</comments>
            <pubDate>Fri, 31 Aug 2007 00:42:21 +0100</pubDate>
            <guid isPermaLink="false">832653</guid>        </item>
        <item>
            <title>More halorhodopsin</title>
            <link>http://www.medworm.com/index.php?rid=522932&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2007%2F04%2F05%2Fmore-halorhodopsin%2F</link>
            <description>This week&amp;#8217;s Nature has quite a few additional halorhodopsin articles for photochannel fans.
	Halorhodopsin article from Deisseroth&amp;#8217;s lab:
Multimodal fast optical interrogation of neural circuitry [News &amp;#038; Views]
	Also, there is an intriguing article on both the general excitement in the neuroscience community with this new technology and a possible intellectual property dispute over it. (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=522932</comments>
            <pubDate>Thu, 05 Apr 2007 05:48:47 +0100</pubDate>
            <guid isPermaLink="false">522932</guid>        </item>
        <item>
            <title>Optical silencing Cl- channel</title>
            <link>http://www.medworm.com/index.php?rid=486192&amp;cid=t_196773_122_f&amp;fid=35066&amp;url=http%3A%2F%2Fneurodudes.com%2F2007%2F03%2F09%2Foptical-silencing-cl-channel%2F</link>
            <description>Ed strikes again!
Two-Color, Bi-Directional Optical Voltage Control of Genetically-Targeted Neurons
	Having found a powerful method for activating neurons with blue light in the protein Channelrhodopsin-2 (ChR2) [1], we sought to augment the toolbox by finding a single-component system capable of mediating light-elicited neuronal inhibition. We identified a powerful tool, the mammalian codon-optimized version of the light-driven chloride pump halorhodopsin, from the archaebacterium Natronobacterium pharaonis (here abbreviated Halo) [2]. (Source: neurodudes)</description>
            <author>neurodudes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=486192</comments>
            <pubDate>Sat, 10 Mar 2007 04:40:56 +0100</pubDate>
            <guid isPermaLink="false">486192</guid>        </item>
    </channel>
</rss>

